ID ASM_BOVIN Reviewed; 625 AA. AC Q0VD19; DT 29-MAY-2007, integrated into UniProtKB/Swiss-Prot. DT 05-SEP-2006, sequence version 1. DT 24-JAN-2024, entry version 101. DE RecName: Full=Sphingomyelin phosphodiesterase; DE EC=3.1.4.12 {ECO:0000250|UniProtKB:P17405}; DE EC=3.1.4.3 {ECO:0000250|UniProtKB:P17405}; DE AltName: Full=Acid sphingomyelinase; DE Short=aSMase; DE Contains: DE RecName: Full=Sphingomyelin phosphodiesterase, processed form {ECO:0000305}; DE Flags: Precursor; GN Name=SMPD1; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Hereford; TISSUE=Thalamus; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Converts sphingomyelin to ceramide. Exists as two enzymatic CC forms that arise from alternative trafficking of a single protein CC precursor, one that is targeted to the endolysosomal compartment, CC whereas the other is released extracellularly. However, in response to CC various forms of stress, lysosomal exocytosis may represent a major CC source of the secretory form. {ECO:0000250|UniProtKB:P17405}. CC -!- FUNCTION: In the lysosomes, converts sphingomyelin to ceramide. Plays CC an important role in the export of cholesterol from the CC intraendolysosomal membranes. Also has phospholipase C activities CC toward 1,2-diacylglycerolphosphocholine and 1,2- CC diacylglycerolphosphoglycerol. Modulates stress-induced apoptosis CC through the production of ceramide. {ECO:0000250|UniProtKB:P17405}. CC -!- FUNCTION: When secreted, modulates cell signaling with its ability to CC reorganize the plasma membrane by converting sphingomyelin to ceramide. CC Secreted form is increased in response to stress and inflammatory CC mediators such as IL1B, IFNG or TNF as well as upon infection with CC bacteria and viruses. Produces the release of ceramide in the outer CC leaflet of the plasma membrane playing a central role in host defense. CC Ceramide reorganizes these rafts into larger signaling platforms that CC are required to internalize bacteria, induce apoptosis and regulate the CC cytokine response in infected cells. In wounded cells, the lysosomal CC form is released extracellularly in the presence of Ca(2+) and promotes CC endocytosis and plasma membrane repair. {ECO:0000250|UniProtKB:P17405}. CC -!- FUNCTION: [Sphingomyelin phosphodiesterase, processed form]: This form CC is generated following cleavage by CASP7 in the extracellular milieu in CC response to bacterial infection (By similarity). It shows increased CC ability to convert sphingomyelin to ceramide and promotes plasma CC membrane repair. Plasma membrane repair by ceramide counteracts the CC action of gasdermin-D (GSDMD) perforin (PRF1) pores that are formed in CC response to bacterial infection (By similarity). CC {ECO:0000250|UniProtKB:Q04519}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a sphingomyelin + H2O = an N-acylsphing-4-enine + H(+) + CC phosphocholine; Xref=Rhea:RHEA:19253, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:17636, ChEBI:CHEBI:52639, CC ChEBI:CHEBI:295975; EC=3.1.4.12; CC Evidence={ECO:0000250|UniProtKB:P17405}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19254; CC Evidence={ECO:0000250|UniProtKB:P17405}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + N-(octadecanoyl)-sphing-4-enine-1-phosphocholine = H(+) CC + N-octadecanoylsphing-4-enine + phosphocholine; CC Xref=Rhea:RHEA:54284, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:72961, ChEBI:CHEBI:83358, ChEBI:CHEBI:295975; CC Evidence={ECO:0000250|UniProtKB:P17405}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54285; CC Evidence={ECO:0000250|UniProtKB:P17405}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1,2-diacyl- CC sn-glycerol + H(+) + phosphocholine; Xref=Rhea:RHEA:10604, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, CC ChEBI:CHEBI:57643, ChEBI:CHEBI:295975; EC=3.1.4.3; CC Evidence={ECO:0000250|UniProtKB:P17405}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10605; CC Evidence={ECO:0000250|UniProtKB:P17405}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + H2O = 1,2- CC dihexadecanoyl-sn-glycerol + H(+) + phosphocholine; CC Xref=Rhea:RHEA:45304, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:72999, ChEBI:CHEBI:82929, ChEBI:CHEBI:295975; CC Evidence={ECO:0000250|UniProtKB:P17405}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45305; CC Evidence={ECO:0000250|UniProtKB:P17405}; CC -!- CATALYTIC ACTIVITY: [Sphingomyelin phosphodiesterase, processed form]: CC Reaction=a sphingomyelin + H2O = an N-acylsphing-4-enine + H(+) + CC phosphocholine; Xref=Rhea:RHEA:19253, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:17636, ChEBI:CHEBI:52639, CC ChEBI:CHEBI:295975; EC=3.1.4.12; CC Evidence={ECO:0000250|UniProtKB:Q04519}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19254; CC Evidence={ECO:0000250|UniProtKB:Q04519}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; CC Evidence={ECO:0000250|UniProtKB:P17405}; CC Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000250|UniProtKB:P17405}; CC -!- ACTIVITY REGULATION: Hydrolysis of liposomal sphingomyelin is CC stimulated by incorporation of diacylglycerol (DAG), ceramide and free CC fatty acids into the liposomal membranes. Phosphatidylcholine CC hydrolysis is inhibited by incorporation of cholesterol, ceramide, DAG, CC monoacylglycerol and fatty acids. {ECO:0000250|UniProtKB:P17405}. CC -!- SUBUNIT: Monomer. Interacts with SORT1; the interaction is required for CC SMPD1 targeting to lysosomes. {ECO:0000250|UniProtKB:P17405}. CC -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000250|UniProtKB:P17405}. Lipid CC droplet {ECO:0000250|UniProtKB:P17405}. Secreted CC {ECO:0000250|UniProtKB:P17405}. Note=The secreted form is induced in a CC time- and dose-dependent by IL1B and TNF as well as stress and viral CC infection. This increase of the secreted form seems to be due to CC exocytosis of the lysosomal form and is Ca(2+)-dependent. Secretion is CC dependent of phosphorylation at Ser-504. Secretion is induced by CC inflammatory mediators such as IL1B, IFNG or TNF as well as infection CC with bacteria and viruses. {ECO:0000250|UniProtKB:P17405}. CC -!- SUBCELLULAR LOCATION: [Sphingomyelin phosphodiesterase, processed CC form]: Secreted, extracellular space {ECO:0000250|UniProtKB:Q04519}. CC Note=This form is generated following cleavage by CASP7. CC {ECO:0000250|UniProtKB:Q04519}. CC -!- PTM: Proteolytically processed. Mature lysosomal form arises from C- CC terminal proteolytic processing of pro-sphingomyelin phosphodiesterase. CC {ECO:0000250|UniProtKB:P17405}. CC -!- PTM: Both lysosomal and secreted forms are glycosylated but they show a CC differential pattern of glycosylation. {ECO:0000250|UniProtKB:P17405}. CC -!- PTM: Phosphorylated at Ser-504 by PRKCD upon stress stimuli. CC Phosphorylation is required for secretion. CC {ECO:0000250|UniProtKB:P17405}. CC -!- PTM: [Sphingomyelin phosphodiesterase, processed form]: This form is CC generated following cleavage by CASP7 in the extracellular milieu (By CC similarity). It shows increased activity (By similarity). CC {ECO:0000250|UniProtKB:Q04519}. CC -!- MISCELLANEOUS: There are two types of sphingomyelinases: ASM (acid), CC and NSM (neutral). CC -!- SIMILARITY: Belongs to the acid sphingomyelinase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BC119881; AAI19882.1; -; mRNA. DR RefSeq; NP_001068655.1; NM_001075187.1. DR AlphaFoldDB; Q0VD19; -. DR SMR; Q0VD19; -. DR STRING; 9913.ENSBTAP00000020758; -. DR BindingDB; Q0VD19; -. DR ChEMBL; CHEMBL4295808; -. DR GlyCosmos; Q0VD19; 6 sites, No reported glycans. DR PaxDb; 9913-ENSBTAP00000020758; -. DR Ensembl; ENSBTAT00000020758.4; ENSBTAP00000020758.3; ENSBTAG00000015628.4. DR GeneID; 505097; -. DR KEGG; bta:505097; -. DR CTD; 6609; -. DR VEuPathDB; HostDB:ENSBTAG00000015628; -. DR VGNC; VGNC:35029; SMPD1. DR eggNOG; KOG3770; Eukaryota. DR GeneTree; ENSGT00950000183182; -. DR HOGENOM; CLU_014743_3_1_1; -. DR InParanoid; Q0VD19; -. DR OMA; VWSQTRK; -. DR OrthoDB; 205363at2759; -. DR TreeFam; TF313674; -. DR Reactome; R-BTA-9840310; Glycosphingolipid catabolism. DR Proteomes; UP000009136; Chromosome 15. DR Bgee; ENSBTAG00000015628; Expressed in pons and 103 other cell types or tissues. DR GO; GO:0036019; C:endolysosome; ISS:UniProtKB. DR GO; GO:0005615; C:extracellular space; ISS:UniProtKB. DR GO; GO:0005811; C:lipid droplet; IEA:UniProtKB-SubCell. DR GO; GO:0005765; C:lysosomal membrane; IDA:AgBase. DR GO; GO:0005764; C:lysosome; IDA:AgBase. DR GO; GO:0045121; C:membrane raft; IDA:AgBase. DR GO; GO:0005886; C:plasma membrane; IEA:Ensembl. DR GO; GO:0061750; F:acid sphingomyelin phosphodiesterase activity; ISS:UniProtKB. DR GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:UniProtKB-KW. DR GO; GO:0034480; F:phosphatidylcholine phospholipase C activity; IEA:RHEA. DR GO; GO:0004767; F:sphingomyelin phosphodiesterase activity; ISS:UniProtKB. DR GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB. DR GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB. DR GO; GO:0034644; P:cellular response to UV; ISS:UniProtKB. DR GO; GO:0046513; P:ceramide biosynthetic process; IDA:AgBase. DR GO; GO:0008203; P:cholesterol metabolic process; IEA:Ensembl. DR GO; GO:0001778; P:plasma membrane repair; ISS:UniProtKB. DR GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB. DR GO; GO:0045807; P:positive regulation of endocytosis; ISS:UniProtKB. DR GO; GO:0035307; P:positive regulation of protein dephosphorylation; IEA:Ensembl. DR GO; GO:0046598; P:positive regulation of viral entry into host cell; IEA:Ensembl. DR GO; GO:0070555; P:response to interleukin-1; ISS:UniProtKB. DR GO; GO:0010212; P:response to ionizing radiation; ISS:UniProtKB. DR GO; GO:0034612; P:response to tumor necrosis factor; ISS:UniProtKB. DR GO; GO:0034340; P:response to type I interferon; ISS:UniProtKB. DR GO; GO:0009615; P:response to virus; ISS:UniProtKB. DR GO; GO:0006685; P:sphingomyelin catabolic process; ISS:UniProtKB. DR GO; GO:0023021; P:termination of signal transduction; IEA:Ensembl. DR GO; GO:0046718; P:viral entry into host cell; ISS:UniProtKB. DR GO; GO:0042060; P:wound healing; ISS:UniProtKB. DR CDD; cd00842; MPP_ASMase; 1. DR Gene3D; 3.60.21.10; -; 1. DR InterPro; IPR045473; ASM_C. DR InterPro; IPR041805; ASMase/PPN1_MPP. DR InterPro; IPR004843; Calcineurin-like_PHP_ApaH. DR InterPro; IPR029052; Metallo-depent_PP-like. DR InterPro; IPR011001; Saposin-like. DR InterPro; IPR008139; SaposinB_dom. DR InterPro; IPR011160; Sphingomy_PDE. DR PANTHER; PTHR10340; SPHINGOMYELIN PHOSPHODIESTERASE; 1. DR PANTHER; PTHR10340:SF34; SPHINGOMYELIN PHOSPHODIESTERASE; 1. DR Pfam; PF19272; ASMase_C; 1. DR Pfam; PF00149; Metallophos; 1. DR PIRSF; PIRSF000948; Sphingomy_PDE; 1. DR SMART; SM00741; SapB; 1. DR SUPFAM; SSF56300; Metallo-dependent phosphatases; 1. DR SUPFAM; SSF47862; Saposin; 1. DR PROSITE; PS50015; SAP_B; 1. PE 2: Evidence at transcript level; KW Disulfide bond; Glycoprotein; Glycosidase; Hydrolase; Lipid droplet; KW Lipid metabolism; Lysosome; Metal-binding; Phosphoprotein; KW Reference proteome; Secreted; Signal; Zinc. FT SIGNAL 1..40 FT /evidence="ECO:0000255" FT CHAIN 41..625 FT /note="Sphingomyelin phosphodiesterase" FT /id="PRO_0000288775" FT CHAIN 248..625 FT /note="Sphingomyelin phosphodiesterase, processed form" FT /evidence="ECO:0000250|UniProtKB:Q04519" FT /id="PRO_0000456683" FT DOMAIN 81..165 FT /note="Saposin B-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT REGION 1..20 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 202 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P17405" FT BINDING 204 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P17405" FT BINDING 274 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P17405" FT BINDING 274 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P17405" FT BINDING 314 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P17405" FT BINDING 421 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P17405" FT BINDING 453 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P17405" FT BINDING 455 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P17405" FT SITE 247..248 FT /note="Cleavage; by CASP7" FT /evidence="ECO:0000250|UniProtKB:Q04519" FT MOD_RES 504 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P17405" FT CARBOHYD 82 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT CARBOHYD 171 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT CARBOHYD 331 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT CARBOHYD 391 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT CARBOHYD 499 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT CARBOHYD 516 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT DISULFID 85..161 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT DISULFID 88..153 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT DISULFID 116..127 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT DISULFID 217..222 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT DISULFID 223..246 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT DISULFID 381..427 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT DISULFID 580..584 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" FT DISULFID 590..603 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00415" SQ SEQUENCE 625 AA; 69392 MW; 1A87AAFEDDC0C959 CRC64; MPRHGVSPGQ GLPRSGREQA SDRSLGAPCL RLLWLGLALA LALPNSPVLW SPAEARPLPT QGHPAKFIRI APQLQEAFGW WNLTCPTCKG LFTAIDFGLR NQASVAWVGS VAIKLCVLLK IAPPAVCQSA VQLFEDDMVE VWTRSVLSPS EACGLLLGSS CGHWDIFSSW NISLPAVPKP PPQPPKPPAP GSPVSRVLFL TDLHWDHDYL EGTDPNCENP LCCRRDSGPP PASQPGAGYW GEYSKCDLPL RTLESLLSGL GPAGPFDMVY WTGDIPAHNI WQQSRQDQLR ALTTITALVK KFLGPVPVYP AVGNHESTPV NGFPPPFIKG NQSSHWLYEA MAEAWEPWLP AEALRTLRIG GFYALSPRPG LRLISLNMNF CSRENFWLLI NSTDPAGQLQ WLVGELQAAE DRGDKVHIIG HIPPGHCLKS WSWNYYRIVE RYENTLAGQF FGHTHVDEFE VFYDEETLSR PLSVAFLAPS ATTYIGLNPG YRVYQIDGNY SGSSHVVLDH ETYIMNLTEA NEPGATPHWY LLYRARETYG LPNALPTAWH DLVYRMRKDT QLFQTFWFLY HKGHPPSEPC GTPCRLATLC AQLSARSDSP ALCRHLVPDA SLPDVQSLWS MPLLC //